Product ID |
CAS Number |
Product Name |
Quantity |
AS-0060 |
56990-02-4 |
3,5-Dibromobenzaldehyde |
|
AS-0482 |
775-00-8 |
2-(4-TRIFLUOROMETHYL-PHENYL)-ETHYLAMINE |
|
AS-0840 |
2105-96-6 |
4-Fluoro-3-nitrophenol |
|
AS-2629 |
701-45-1 |
3-Bromo-4-fluoronitrobenzene |
|
AS-2637 |
34841-06-0 |
3-Bromo-4-methoxybenzaldehyde |
|
AS-2640 |
86265-88-5 |
3-BROMO-4-CHLORO-BENZALDEHYDE |
|
AS-2963 |
37772-93-3 |
5-Methylpyrrolidine-2,4-dione |
|
AS-2974 |
5202-89-1 |
Methyl 5-chloroanthranilate |
|
AS-4743 |
375-22-4 |
Heptafluorobutyric acid |
|
AS-5084 |
95-51-2 |
2-Chloroaniline |
|
AS-5123 |
2682-49-7 |
1,3-THIAZOLIDIN-2-ONE |
|
AS-5135 |
17356-19-3 |
1-ETHYNYLCYCLOPENTANOL |
|
AS-5846 |
14345-97-2 |
2-Chloro-3-methylthiophene |
|
AS-5855 |
3562-99-0 |
3-(4-METHOXY-1-NAPHTHOYL)PROPIONIC ACID |
|
AS-5964 |
82689-19-8 |
N-alpha-Boc-L-tryptophanol |
|
AS-5978 |
76757-91-0 |
BOC-TYR(ET)-OH |
|
AS-6057 |
54439-75-7 |
2-Chloro-4-hydroxybenzaldehyde 98% |
|
AS-6364 |
39684-80-5 |
tert-Butyl N-(2-bromoethyl)carbamate |
|
AS-6492 |
999-21-3 |
DIALLYL MALEATE |
|
AS-6494 |
1501-27-5 |
METHYL HYDROGEN GLUTARATE |
|
AS-6667 |
249649-08-6 |
3,4-Difluoro-D-phenylalanine |
|
AS-6709 |
1946-82-3 |
AC-LYS-OH |
|
AS-6717 |
73590-58-6 |
Omeprazole |
|
AS-7154 |
717843-47-5 |
3-BROMO-2-METHOXY-6-PICOLINE |
|
AS-7200 |
4562-27-0 |
4-Pyrimidinol |
|
AS-7589 |
443913-73-3 |
Vandetanib |
|
AS-7775 |
96923-01-2 |
2'-METHOXY-BIPHENYL-3-YLAMINE HYDROCHLORIDE |
|
AS-7783 |
17345-61-8 |
3,4-Dihydroxybenzonitrile |
|
AS-7851 |
1075705-01-9 |
4-fluoro-2-Methoxy-5-nitroaniline |
|
AS-8012 |
52665-49-3 |
FURAN-3-SULFONYL CHLORIDE |
|
AS-8013 |
55552-70-0 |
3-Furanboronic acid |
|
AS-8162 |
5458-84-4 |
2-IODO-5-NITROANISOLE |
|
JR02-H061 |
889944-57-4 |
6-Oxospiro[3.3]heptane-2-carboxylic acid |
|
JR6-L2152 |
1269963-27-0 |
Benzenepropanoic acid, ß-amino-2,4,5-trifluoro-, (ßS)- |
|
JR6-L4326 |
585538-15-4 |
2,5-Pyrrolidinedione, 1,1'-[dithiobis[(1-oxo-16,1-hexadecanediyl)oxy]]bis- (9CI) |
|
JR6-L8768 |
1026660-51-4 |
4-Heptyn-2-ol, 1-chloro-, (2S)- |
|
|
|
|
|
|
|
|
|
|
|
|
|